9 Results for "

antischizophrenia

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "antischizophrenia" in MCE Product Catalog:

Cat. No.: HY-154487
CAS No.: 25637-84-7
Research Areas:  

Neurological Disease

Glycerol dioleate is a lipid capable of forming Lyotropic Liquid Crystal (LLC). When formulated with phosphatidylcholine and exposed to aqueous media, glycerol dioleate constructs an inverted hexagonal (HII) phase structure with sustained-release properties. The in-situ forming gel prepared by optimizing glycerol dioleate with phosphatidylcholine and N-methyl-2-pyrrolidone enables stable release of Risperidone (HY-11018) for up to 60 days in vitro and in vivo. Glycerol dioleate causes minimal side effects in rabbits, making it an ideal carrier component for the development of antischizophrenia agents .Note: Lyotropic liquid crystals (Lyotropic Liquid Crystal, LLC) are ordered fluid phases self-assembled by amphipathic molecules (e.g., lipids, surfactants) in solvents (usually water) at specific concentrations .
loading...
    loading...
Cat. No.: HY-14562
CAS No.: 634616-95-8
Purity:  99.74%
TBPB (tert-butyl peroxybenzoate) is a highly selective, blood-brain-permeable M1 mAChR allosteric agonist (EC50=289 nM) with anti-schizophrenia and anti-inflammatory activities. TBPB can enhance the sensitivity of M1 receptors to acetylcholine, activate downstream signaling pathways, and inhibit the release of pro-inflammatory cytokines (TNF-α, IL-6). TBPB can regulate the processing of amyloid and can be used in the study of neurodegenerative diseases (such as Alzheimer's disease) and inflammation-related diseases (such as sepsis) .
loading...
    loading...
Cat. No.: HY-10715
CAS No.: 615571-23-8
Purity:  99.82%
Target:  

GlyT

Research Areas:  

Neurological Disease

SSR504734 is an orally active, selective and reversible inhibitor of human, rat, and mouse GlyT1 (IC50=18, 15, and 38 nM, respectively). SSR504734 shows anti-schizophrenia, anti-anxiety and anti-depression activities .
loading...
    loading...
Cat. No.: HY-149651
CAS No.: 2983118-29-0
Purity:  99.80%
Target:  

GPR139

Research Areas:  

Neurological Disease

GPR139 agonist-2 (compound 20a) is a potent GPR139 agonist with an EC50 of 24.7 nM. GPR139 agonist-2 rescues the social interaction deficits and alleviates cognitive deficits in murine schizophrenia models. GPR139 agonist-2 has the potential for antischizophrenia drug research .
loading...
    loading...
Cat. No.: HY-N3624
CAS No.: 91653-75-7
Coriatin can be isolated from L. parasiticus and has antischizophrenia activity .
loading...
    loading...
Cat. No.: HY-103406
CAS No.: 250266-51-4
PNU-177864 is a potent, selective, orally active dopamine D3 receptor antagonist. PNU-177864 induces phospholipid metabolism in vivo and has anti-schizophrenia activity .
loading...
    loading...
Cat. No.: HY-103406A
CAS No.: 1783978-03-9
Target:  

Dopamine Receptor CCR

Research Areas:  

Neurological Disease

PNU-177864 is a potent, selective, orally active dopamine D3 receptor antagonist. PNU-177864 induces phospholipid metabolism in vivo and has anti-schizophrenia activity .
loading...
    loading...
Cat. No.: HY-114895
CAS No.: 742693-38-5
Target:  

GlyT

Research Areas:  

Neurological Disease

SSR504734 free base is an orally active, selective and reversible inhibitor of human, rat, and mouse GlyT1 (IC50=18, 15, and 38 nM, respectively). SSR504734 free base shows anti-schizophrenia, anti-anxiety and anti-depression activities .
loading...
    loading...
Cat. No.: HY-10715R
CAS No.: 615571-23-8
Research Areas:  

Neurological Disease

SSR504734 (Standard) is the analytical standard of SSR504734 (HY-10715). This product is intended for research and analytical applications. SSR504734 is an orally active, selective and reversible inhibitor of human, rat, and mouse GlyT1 (IC50=18, 15, and 38 nM, respectively). SSR504734 shows anti-schizophrenia, anti-anxiety and anti-depression activities .
loading...
    loading...